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Abstract
 .   .  .  .  .4 1H -quinolones 2-alkyl- 1 , 2-alkyl-3-methyl- 2 , 2-methyl-3-alkyl- 3 , 1-hydroxy-2-methyl-3-alkyl- 4 and
 ..1-hydroxy-2-alkyl- 5 with n-alkyl side chains varying from C to C have been synthesized and tested for biological5 17
activity in mitochondrial complexes. Whereas all quinolones were efficient inhibitors of electron transport in the
cytochrome brc -complex from either beef heart or Rhodospirillum rubrum, in complex I from beef heart quinolones 11
 .and 2 only were highly active. In a Quantitative Structure-Activity Relationship QSAR inhibitory activity in the
cytochrome brc -complexes could be correlated to the physicochemical parameters lipophilicity p andror to STERIMOL1
˚L. Maximal inhibitory potency was achieved at a carbon chain length of 12–14 A. Oxidant-induced reduction of
cytochrome b established that some quinolones are inhibitors of the Q rather than the Q site.p n
Keywords: NADH:ubiquinone oxidoreductase; Cytochrome bc complex; Q -site inhibitor; Oxidant-induced reduction; Structure–activity1 p
 .  .relationship; Beef heart ; Rhodospirillum rubrum
1. Introduction
The mitochondrial NADH:ubiquinone oxidoreduc-
 .tase complex I transfers electrons and protons as
well accross the inner membrane. It is one of the
most complicated membrane complexes. In mam-
w xmalians, it consists of at least 41 protein subunits 1 .
Though all their sequences are known, there is little
information available about the function of the pro-
teins and the binding of the cofactors FMN and
. several iron-sulfur clusters to them for a recent
w x.review, see 2 .
) Corresponding author. Fax: q49 234 7094322.
Inhibitors can serve as useful tools to elucidate
structural and mechanistic aspects of enzyme reac-
tions. The inhibitors of complex I, known so far, are
mostly of natural origin, like piericidins and rotenone.
Most recently, a series of other natural substances,
like annonins, aurachins, and thiangazole, to quote
only a few, have been found to be potent inhibitors of
w xcomplex I 3 . The most powerful inhibitors of com-
plex I known so far are natural substances
 .acetogenins from the family Annonaceae, which in
their biological activity are even better then piericidin
w xor rotenone 4 . The inhibitors mentioned so far have
w xat least two 3 , possibly even three though overlap-
w xping binding sites 4 .
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Ubiquinol, reduced at complex I, is reoxidized at
 .the cytochrome brc -complex complex III under1
reduction of cytochrome c. Compared to complex I,
complex III is relatively simple and contains only
three redox carriers: cytochrome b, cytochrome c and
the Rieske iron-sulfur protein. Ubiquinol and its oxi-
 .dized species ubiquinone, -semiquinone bind to two
different loci, designated as Q and Q . Inhibitors ofn p
both sites are well known, for example for the Q -sitep
strobilurin, myxothiazol, UHDBT undecylhydroxy-
.dioxobenzothiazole and stigmatellin and for the Q -n
site antimycin, funicolusin and HQNO heptyl-hy-
 .droxyquinoline-N-oxide; 1-hydroxy-2-heptyl-4 1H -
.  w x.quinolone for review, see 5 .
Though the biological activity of some 2-alkyl-
 .4 1H -quinolones, isolated from the culture filtrates
of Pseudomonas aeroginosa is known since 40 years
w x6 , the influence of the substitution pattern and the
length of the alkyl chain on the inhibitory potency of
the quinolones and their N-oxides has not been inves-
tigated. Only HQNO has been thoroughly studied for
w x.example 7 , because it is commercially available. In
addition, the effect of some 2- and 3-arylalkyl-
 .4 1H quinolones on mitochondrial electron transport
has been examined, though their site of action was
w xnot specified 8 .
We wish to report here on the inhibitory activities
 . of alkyl- and methyl-alkyl-4 1H -quinolones Fig. 1,
.  .1–3 and their corresponding N-oxides Fig. 1., 4–5
on mitochondrial complexes. The inhibitory potency
of the quinolones reached a maximum at a chain
 .  .Fig. 1. Structures of 2-alkyl-4 1H -quinolone 1 , 2-alkyl-3-
 .  .  .methyl-4 1H -quinolone 2 , 2-methyl-3-alkyl-4 1H -quinolone
 .  .  .3 , 1-hydroxy-2-methyl-3-alkyl-4 1H -quinolone 4 , and 1-hy-
 .  .droxy-2-alkyl-4 1H quinolone 5 .
˚length of the alkyl group of about 14–15 A and
decreased if the chain length was further increased.
Furthermore, for the first time a QSAR Quantitative
.Structure-Activity Relationship of quinolone in-
hibitors in the cytochrome brc -complex will be1
presented.
2. Materials and methods
2.1. Chemicals
2.1.1. Synthesis of quinolones
( ) ( )2.1.1.1. 2-alkyl- 1 and 2-alkyl-3-methyl-4 1H -
( )  .quinolones 2 . The 2-alkyl- 1 and 2-alkyl-3-
 .  .methyl-4 1H -quinolones 2 were prepared by alky-
lation of the corresponding dianions, generated by
addition of two equivalents of n-butyl-lithium in
tetrahydrofuran at y208C, with alkyl-halogenides.
( ) ( )2.1.1.2. 3-alkyl-2-methyl-4 1H -quinolones 3 . The
 .  .3-alkyl-2-methyl-4 1H -quinolones 3 were obtained
w xby the Conrad-Limpach cyclization procedure 9 .
Aniline is reacted with a suitable substituted acety-
lacetic acid ester to yield the corresponding b-anilino
crotonic acid ester, which undergoes ring closure in
diphenylether at 2608C.
( )2.1.1.3. 3-alkyl-1-hydroxy-2-methyl-4 1H -quinolones
( )4 . For the synthesis of the 3-alkyl-1-hydroxy-2-
 .  .methyl-4 1H -quinolones 4 the keto group in the
4-position was protected by conversion into the p-
methoxybenzylether, the corresponding ether was
converted into the 1-hydroxy compound by oxidation
with 3-chloroperbenzoic acid. Finally, the p-
methoxybenzl protecting group was removed by cat-
alytic hydrogenation.
( ) ( )2.1.1.4. 2-alkyl-1-hydroxy-4 1H -quinolones 5 . 2-al-
 .  .kyl-1-hydroxy-4 1H -quinolones 5 were synthe-
w xsized according to Cornforth and James 10 . The
keto group in the 4-position was protected by conver-
sion into the O-ethoxycarbonyl-quinoline. Oxidation
to the 1-hydroxy compound was achieved with 3-
chloroperbenzoic acid. The protecting group was re-
moved by alkaline hydrolysis.
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2.2. Biochemical methods
The preparation of mitochondria and submito-
w xchondrial particles is described in 11 and that of
ubiquinol:cytochrome c oxidoreductase complex III,
.cytochrome brc -complex from beef heart or Rho-1
w xdospirillum rubrum in 12 . The biological activities
of the quinolones in the above complexes were deter-
w x w xmined using protocols given in 11 or 12 , respec-
tively.
Oxidant-induced reduction of cytochrome b in
submitochondrial particles was measured in a dual-
wavelength spectrophotometer at 562 versus 577 nm.
The reaction system in 2 ml contained 25 mM phos-
 .phate pH 7.2 , 125 mM saccharose, 0.1 mM EDTA,
0.1 mgrml dodecyl-b-D-maltoside, 0.1 mM KCN
and cytochrome b at a concentration of 1.5 mM.
Ubiquinol-2 was added at a concentration of 100 mM
and ferricyanide at 16 mM. The concentrations of
antimycin, myxathiazol and the quinolones were 2
mM. They were incubated for 15 s.
2.3. QSAR calculations
Regression equations were calculated on a Power
Macintosh 7200r90 using the statistical package
Minitab 10 Xtra from Minitab, State College, PA,
w xUSA. The p-values were taken from 13 , the L-val-
w xues from 14 . Values for the longer alkyl chains had
to be extrapolated.
3. Results
( )3.1. NADH:ubiquinone-oxidoreductase complex I
The pI -values for inhibition of electron transport50
through mitochondrial complex I from beef heart are
given in Table 1. It should be noted that all 2-methyl-
 .  )3-alkyl-4 1H -quinolones 3 tested proved to be
 .completely inactive data not shown . 1-Hydroxy-2-
 .  .methyl-3-alkyl- 4 and 1-hydroxy-2-alkyl-4 1H -
 .quinolones 5 were only moderate inhibitors, whereas
 .  .the 2-alkyl- 1 and 2-alkyl-3-methyl-4 1H -quino-
 .lones 2 exhibit high inhibitory potency, the latter
being so far the best quinolone-type inhibitors of
complex I pI -value of 7.70 for 2-n-undecyl-3-50
 . .methyl-4 1H -quinolone; Table 1 . It is noteworthy,
that the inhibitory activity of all quinolones increases
with the chain length of the alkyl group until a
maximum is reached at 12 carbon atoms which corre-
˚ sponds to a length of about 14 A Table 1 and Fig.
.2 . Further increase of the chain length lowers the
 .activity Table 1 .
In order to gain more insight on the mode of action
of quinolones on mitochondrial complex I, 2-n-unde-
 .cyl-3-methyl-4 1H -quinolone was studied in more
detail. The kinetics of NADH-reduction at the ex-
pense of ubiquinol-1 was examined at various con-
centrations of this quinolone. The Lineweaver-Burk
plot of the kinetic data is shown in Fig. 3. As is
evident from the regression lines, they share a com-
Table 1
p I values for inhibition of electron transport through complex I from beef heart by quinolones50
1 2 4 5
 .4 1H -quinolone 2-alkyl- 2-alkyl-3-methyl- 1-hydroxy-2-methyl-3-alkyl- 1-hydroxy-2-alkyl-
n-pentyl 4.61 -4
n-hexyl -4
n-heptyl 5.09 6.57 -4 -4
n-octyl 6.81 4.07 -4
n-nonyl 6.03 7.49 4.15 4.37
n-decyl 7.65 4.38 4.60
n-undecyl 6.66 7.70 4.42 4.99
n-dodecyl 7.10 4.24 4.72
n-tridecyl 5.93 6.98 4.22 4.65
n-tetradecyl 4.19 4.38
n-hexadecyl -4
n-heptadecyl -4
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˚ .Fig. 2. Plot of Verloop’s STERIMOL parameter L A of the
alkyl substituent vs. the p I -value of quinolones in beef heart50
mitochondrial complex I. ‘, 1; v, 2; ’, 4; I, 5.
mon x-intercept, but have different y-intercepts. This
indicates a noncompetitive displacement behaviour.
(3.2. Ubiquinol:cytochrome c-oxidoreductase cyto-
)chrome brc -complex1
All quinolones tested so far are also potent in-
hibitors of electron transport through the mitochon-
 .drial complex III from beef heart Table 2 . The
 .highest activity is found for 2-alkyl-3-methyl-4 1H -
 .  .quinolones 2 , where 2-n-undecyl-3-methyl-4 1H -
quinolone with a p I value of 8.05 is the most active50
compound. The other quinolones are only slightly
less active. Biological activity peaks again at a length
of the carbon alkyl chain between 10 and 14 carbon
Fig. 3. Lineweaver-Burk plot of the kinetics of NADH-reduction
by submitochondrial particles from beef heart in the presence of
 . -83-methyl-2-n-undecyl-4- 1H -quinolone. q, control; B, 10 M;
‘, 3P10-8 M; ^, 5P10-8 M.
 .atoms Fig. 4 which corresponds to a chain length of
˚14–18 A.
Similarily, the quinolones were also efficient in-
hibitors of electron transport in the cytochrome brc1
complex from the photosynthetic bacterium R.
 .rubrum Table 3 . Basically, the inhibition pattern is
 .the same as in complex III from beef heart Fig. 5 .
However, the p I -values of the quinolones in the50
cytochrome brc -complex from R. rubrum in some1
cases are more than one order of magnitude higher as
compared to complex III from beef heart. The most
 .active inhibitor is 1-hydroxy-2-n-tetradecyl-4 1H -
 .quinolone 5 , which exhibits a p I -value of 9.1950
 .Table 3 .
Table 2
p I -values for inhibition of electron transport through complex III from beef heart by quinolones50
1 2 3 4 5
 .4 1H -quinolone 2-alkyl- 2-alkyl-3-methyl- 2-methyl-3-alkyl- 1-hydroxy-2-methyl-3-alkyl- 1-hydroxy-2-alkyl-
n-pentyl 4.64 5.60 4.47
n-hexyl 5.84 5.81 5.09
n-heptyl 5.66 6.12 6.88 6.04 5.82
n-octyl 6.44 7.05 6.33 6.43
n-nonyl 6.31 7.10 7.33 6.52 6.88
n-decyl 7.44 7.56 6.81 7.01
n-undecyl 7.00 8.05 7.46 7.26 7.25
n-dodecyl 7.44 7.58 7.07 7.36
n-tridecyl 6.80 7.30 7.60 6.95 7.57
n-tetradecyl 7.90 6.74 7.44
n-hexadecyl 6.71 6.51
n-heptadecyl 6.49
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˚ .Fig. 4. Plot of Verloop’s STERIMOL parameter L A of the
alkyl substituent versus the p I -value of quinolones in beef heart50
mitochondrial complex III., ‘, 1; v, 2; ^, 3; ’, 4; I, 5.
In order to decide which quinone binding site is
affected by the quinolones, i.e. the Q - or Q -site forn p
w x.review, see 15 , their influence on the ‘oxidant-in-
duced reduction’ of cytochrome b in the cytochrome
brc -complex in submitochondrial particles from1
beef heart has been investigated. If cytochrome c1
and the Rieske iron-sulfur protein are both reduced in
the complex and the Q -site is in addition inhibitedn
by antimycin A, a reduction of cytochrome b by
ubiquinol cannot occur. However, if cytochrome c1
and the Rieske iron-sulfur protein are kept oxidized
by ferricyanide, cytochrome b will be rapidly re-
w xduced 5 . This is demonstrated in Fig. 6. Trace a
serves as a control and no extrareduction of cy-
tochrome b is observed. In contrast, in the presence
˚ .Fig. 5. Plot of Verloop’s STERIMOL parameter L A of the
alkyl substituent versus the p I -value of quinolones in the50
cytochrome brc -complex from R. rubrum. ‘, 1; v, 2; ^, 3;1
’, 4; I, 5.
of antimycin A a fast reduction of cytochrome b
 .occurs trace b . Traces c to f demonstrate that
quinolones HMUQ for abbreviations see legend of
.Fig. 6 , HTQ, MTQ and MUQ do not elicit a re-
sponse similar to that of antimycin A. Therefore, the
quinolones cannot be considered as Q -site inhibitors.n
On the other hand, the ‘oxidant-induced’ reduction of
cytochrome b is blocked by inhibitors of the Q -site,p
 .like myxothiazol trace g . In the presence of myxo-
thiazol, antimycin A is no longer capable to induce a
 .reduction of cytochrome b ‘double kill’; trace h . As
is evident from traces j and k, HTQ and MTQ behave
exactly like myxothiazol and can be classified as true
 .Q -type inhibitors. Contrary HMUQ trace i andp
 .MUQ trace l allow for an extrareduction of cy-
Table 3
p I values for inhibition of electron transport through the cytochrome brc complex from R. rubrum by quinolones50 1
1 2 3 4 5
 .4 1H -quinolone 2-alkyl- 2-alkyl-3-methyl- 2-methyl-3-alkyl- 1-hydroxy-2-methyl-3-alkyl- 1-hydroxy-2-alkyl-
n-pentyl 5.42 5.49 5.74
n-hexyl 6.16 7.13 6.16
n-heptyl 6.60 7.10 6.54 7.23 6.30
n-octyl 7.34 7.34 7.51 6.73
n-nonyl 7.05 7.57 7.42 8.10 6.95
n-decyl 7.85 7.71 8.41 7.63
n-undecyl 7.22 8.12 8.04 8.40 7.74
n-dodecyl 7.92 7.77 8.37 8.44
n-tridecyl 7.15 7.66 7.70 8.53 8.65
n-tetradecyl 7.64 8.37 9.19
n-hexadecyl 7.29 7.79
n-heptadecyl 7.93
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Fig. 6. Oxidant-induced reduction of cytochrome b in isolated complex III from beef heart UQH , ubiquinol-2; AA, antimycin; Fc,2
 .  .  .ferricyanide; Myx, myxothiazole; HMUQ, 1-hydroxy-2-methyl-3-n-undecyl-4 1H -quinolone 4 ; HTQ, 1-hydroxy-2-n-tridecyl-4- 1H -
 .  .  .  .  ..quinolone 5 ; MTQ, 2-methyl-3-n-tetradecyl-4- 1H -quinolone 3 ; MUQ, 3-methyl-2-n-undecyl-4- 1H -quinolone 2 . For conditions,
see Section 2. Trace a, control; traces b–l, addition of various inhibitors, see text for details.
tochrome b in the presence of antimycin A. In that
behaviour they are different from myxothiazol.
4. Discussion
Quinolones are produced by the bacteria Pseu-
domonas aeruginosa and Stigmatella aurantiaca
 .‘aurachins’ and were shown to be inhibitors of
respiratory and photosynthetic electron transport
w xchains as well 6,16 . They were taken as ‘lead
substances’ for synthesis and evaluation of biological
 .activity of a series of 2-alkyl- 1 , 2-alkyl-3-methyl-
 .  .  .2 , 2-methyl-3-alkyl-4 1H -quinolones 3 and 1-hy-
 .droxy-2-methyl-3-alkyl- 4 and 1-hydroxy-2-alkyl-
 .  .4 1H -quinolones 5 . The length of the alkyl side
chain was varied from five to seventeen carbon atoms.
In complex I of the mitochondrial respiratory chain
 .  .2-alkyl-4 1H -quinolones 1 showed pronounced ac-
tivity, which could be substantially increased by an
additional methyl substituent in the 3-position. Con-
 .  .versly, the 2-methyl-3-alkyl-4 1H -quinolones 3 ,
where alkyl and methyl group have changed posi-
tions, are completely inactive. This indicates that the
optimal position for a hydrophobic substituent is the
2- and not the 3-position. Furthermore, substitution of
the nitrogen with a hydroxyl instead of a hydrogen is
 .also detrimental for biological activity. 2-Alkyl- 1
 .  .and 2-alkyl-3-methyl-4- 1H -quinolones 2 reached
maximal activity at a length of the alkyl chain of
eleven carbon atoms which corresponds to about 14
A˚. A similar situation is found for 4-alkyl-or 4-al-
koxy-acridones, which were recently found by us as
efficient inhibitors of electron transport through mito-
w xchondrial complex I 11 . In their case, inhibitory
˚activity peaked at a chain length of about 10 A. If
one takes into account that the acridones as compared
to the quinolones bear an additional aromatic moiety,
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the overall distance from the imino group to the end
of the carbon chain is about the same for both types
of compounds. This further corroborates the notion
that the hydrophobic binding pocket of the inhibitor
binding protein can only accommodate an alkyl side
chain up to an optimal length.
The kinetic data of ubiquinone-1 reduction by
NADH in the presence of 2-n-undecyl-3-methyl-
 .4 1H quinolone have indicated that the quinolone and
ubiquinone-1 displace each other in a noncompetitive
manner. This does not necessarily mean that their
binding sites are completely different. It is known
that rotenone is a noncompetitive inhibitor for
ubiquinone at complex I, but rotenenone isomers,
notably capsaicin and ist analogues, act as competi-
tive inhibitors at high ubiquinone concentrations and
noncompetitive inhibitors at low ubiquinone concen-
w xtrations 17–20 . It is conceivable, therefore, that the
quinolones and ubiquinone share identical or overlap-
ping binding sites.
All quinolones 1-5 synthesized so far are efficient
inhibitors of the cytochrome brc -complexes from1
beef heart and R. rubrum as well. As already stressed,
the p I -values of the quinolones are always higher in50
the R. rubrum complex. The same observation was
made for 2- and 4-substituted acridones as inhibitors
of cytochrome brc complexes, which have been1
w xrecently reported by us 12 . This discrepancy has
w xbeen discussed extensively in 12 . The notion about
the optimal length of the alkyl side chains in
quinolones compared to 2-alkyl- and 4-alkyl-
acridones, as made above, also applies for their in-
hibitory activity in cytochrome brc complexes.1
As is evident from the ‘oxidant-induced reduction’
of cytochrome b, all quinolones testet so far are
definitely no Q -site inhibitors, because they behaven
different from antimycin compare traces b and c to f
.in Fig. 6 . An alternate explanation for the inhibitory
activity of quinolones would be that they are in-
hibitors of the other quinone binding site, the Q -site.p
This is definitely true for HTQ and MTQ, which
behave exactly like the Q -site inhibitor myxothiazolp
 .compare trace h and j and k in Fig. 6 . However,
HMUQ and MUQ induce an extra reduction of cy-
tochrome b in the presence of antimycin and in this
respect are different from myxothiazol see traces h
.and l in Fig. 6 . If the structures of the two 1-hy-
droxy-quinolones HTQ and HMUQ and the two 1-
hydrogen-quinolones MTQ and MUQ are compared,
it is noted that in both groups the bulky alkyl side
chains have changed positions from the 2- to the
3-position and vice versa. It is possible that 1-hy-
droxy- vs. 1-hydrogen-quinolones have a different
orientation within their binding niche. It is possible
that the Q -site cannot accomodate HMUQ and MUQp
and that they bind to a not yet known quinone
binding site which is not identical to the Q -site butp
may be possibly located adjacent. Further work will
be needed to classify the exact mechanism of action
of inhibitors like HMUQ and MUQ.
A QSAR for complex I inhibitors was not possible
because either the data sets were to small or the
variations in pI -values were too low to allow for a50
calculation. However, a QSAR could be performed
for all quinolones in both cytochrome b r c -1
complexes from beef heart and R. rubrum. As
w xphysicochemical parameters, the lipophilicity p 13
w xand Verloop’s STERIMOL parameter L 14 of the
 2.  3.alkyl side chain in positions 2 R and 3 R have
been used. The quinolones have been grouped in two
classes: those bearing a hydrogen at the nitrogen
 .1–3 and those bearing a hydroxyl group at the
 .nitrogen 4–5 . The following equations have been
obtained:
4.1. Cytochrome brc -complex from beef heart1
Quinolones 1–3
p I s1.86q1.57p R2 y0.13p 2 R2 .  .50
q1.88p R3 y0.19p 2 R3 1 .  .  .
ns23; rs0.847; ss0.365; Fs24.91.
Quinolones 4–5:
p I sy0.71q2.93p R2 y0.26p 2 R2 .  .50
q2.50p R3 y0.26p 2 R3 2 .  .  .
ns21; rs0.963; ss0.168; Fs104.23.
4.2. Cytochrome brc -complex from R. rubrum1
Quinolones 1–3:
p I sy1.33q2.73p R2 y0.28p 2 R2 .  .50
q1.05L R3 y0.04L2 R3 3 .  .  .
ns23; rs0.935; ss0.208; Fs64.70.
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Quinolones 4–5:
p I sy2.76q1.05L R2 y0.03L2 R2 .  .50
q1.18 L R3 y0.04L2 R3 4 .  .  .
ns21; rs0.906; ss0.314; Fs38.48.
 .  .In Eqs. 1 – 4 , n is the number of compounds, r
the correlation coefficient, s the SD and F denotes
the F-test of significance.
 .  .In Eqs. 1 – 4 different physicochemical parame-
 .  .ters have been used. Whereas in Eq. 1 and Eq. 2
the lipophilicity parameter p has been applied for
 3.  .both substituents, p R in Eq. 3 has been replaced
 3.  .  2.  3.by L R and in Eq. 4 L R and L R have
been used exclusively. It should be noted that
lipophilicity p and the STERIMOL parameter L
 .length of the substituent are highly intercorrelated.
This is due to the fact that the lipophilicity p in-
creases linearly with the chain length. In the multiple
linear regressions all combinations of parameter sets
have been calculated and the equations with the
highest correlation coefficient r and statistical signifi-
 .cance have been selected. For instance, if in Eq. 3
 3.  3.L R is replaced by p R , r drops from 0.935 to
 2.  3.0.721. Similarly, replacement of L R and L R
 .  2.  3.in Eq. 4 by p R and p R leads to a decrease
in r from 0.906 to 0.698. The use of different
parameter sets does not allow for comparison of the
numerical values of the variables and the constant.
Furthermore, as already stressed, p I -values of50
quinolones in the cytochrome brc -complex of R.1
rubrum are significantly higher than in the complex
from beef heart. Compared to the QSAR of acridone
w x  .  .inhibitors 12 , Eqs. 1 – 4 are very simple and
indicate that biological activity is only governed by
the lipophilicity p andror the length of the alkyl
substituent, or the squares of them, respectively. The
parabolic dependency from STERIMOL parameter L
is already evident from Figs. 4 and 5.
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